Pricing Log in Create free account

Amarin Corporation PLC (AMRN) vs Organon & Co. (OGN)

Amarin Corporation PLC and Organon & Co. are both Drug Manufacturers General companies. Organon & Co. is the larger, with a market value of $3.6B against $244.0M — 14.8× the size. Amarin Corporation PLC has negative trailing earnings, so its P/E is not meaningful; Organon & Co. trades at 17.3×. Organon & Co. grew revenue faster over the last twelve months: −3.21% against −22.3%. Organon & Co. has the higher net margin (3.49% vs −10.9%) and the higher return on invested capital (6.26% vs −16.6%). Across the 21 metrics below, Organon & Co. leads on 13 and Amarin Corporation PLC on 8.

Valuation

Metric AMRN OGN Drug Manufacturers General median
P/E n/m 17.29 26.51
P/S 1.37 0.60 3.49
P/B 0.54 3.04 5.28
Price to free cash flow 6.46 6.35 21.67
EV/EBITDA 2.15 7.51 14.73
EV/Sales (0.36) 1.76 4.15
Earnings yield (7.91%) 5.78% 2.41%
Free cash flow yield 15.49% 15.75% 4.07%

Profitability

Metric AMRN OGN Drug Manufacturers General median
Gross margin 40.94% 53.12% 73.01%
Operating margin (18.19%) 13.63% 18.34%
Net margin (10.87%) 3.49% 7.31%
Free cash flow margin 21.29% 9.38% 18.56%
Return on equity (4.24%) 20.30% 5.80%
Return on assets (2.96%) 1.58% 2.28%
Return on invested capital (16.57%) 6.26% 6.26%

Growth

Metric AMRN OGN Drug Manufacturers General median
Revenue growth (TTM) (22.33%) (3.21%) 6.72%
EPS growth (last fiscal year) 53.25% (78.38%) 21.81%
Revenue growth, 5-year CAGR (19.04%) (0.99%) 4.75%
Net income growth, 5-year CAGR 0.00% (38.70%) 0.00%

Health

Metric AMRN OGN Drug Manufacturers General median
Debt to equity 0.00 7.17 0.62
Current ratio 3.50 2.02 1.39
Net debt to EBITDA 6.42 5.62 1.15

Dividend

Metric AMRN OGN Drug Manufacturers General median
Dividend yield — 0.58% 2.32%
Payout ratio — 0.11 0.59

Size

Metric AMRN OGN Drug Manufacturers General median
Market cap 244.00m 3.62b 129.04b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack